⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRLB News
PROTO LABS, INC.
Form 8-K
sec.gov
PRLB
Protolabs Strengthens Executive Leadership Team with Appointment of Bernardo Parlange as Chief Commercial Officer
businesswire.com
PRLB
Form 8-K
sec.gov
PRLB
Form 8-K
sec.gov
PRLB
Protolabs Reports Financial Results for the First Quarter of 2026
businesswire.com
PRLB
JASMINE Trial Demonstrates Prolacta's Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan's Renowned Low NEC Rate
prnewswire.com
PRLB
Protolabs Sets Conference Call to Discuss First Quarter 2026 Financial Results
businesswire.com
PRLB
Protolabs Joins Space Foundation to Help Propel Aerospace Innovation into a New Space Age
businesswire.com
PRLB
Protolabs to Attend 2026 Cantor Global Technology & Industrial Growth Conference on March 10, 2026
businesswire.com
PRLB
Une première mondiale en soins néonatals : le Japon approuve les fortifiants 100 % à base de lait humain de Prolacta Bioscience en tant que médicament sur ordonnance pour les nourissons vulnérables USA - Français USA - English USA - English USA - español
prnewswire.com
PRLB